Drug Profile
Lutropin alfa
Alternative Names: LHadi; Lutropin; Lutropin-α; Luveris; r-hLH; Recombinant luteinising hormoneLatest Information Update: 23 Sep 2021
Price :
$50
*
At a glance
- Originator Merck Serono
- Class Infertility therapies; Menotropins; Peptide hormones; Pituitary gonadotropins
- Mechanism of Action Luteinising hormone stimulants; Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Female infertility